Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Brazil Infusion Bags market was valued at USD 23.82 Million in 2025 and is expected to grow at a CAGR of 4.10%, reaching USD 35.60 Million by 2035. The market growth is driven by the rising prevalence of chronic diseases, increasing surgical procedures and hospital admissions, growing demand for intravenous therapies, expanding adoption of home-based infusion care, supportive healthcare investments, advancements in infusion technologies, and the increasing preference for safer non-PVC and DEHP-free infusion bags.
Compound Annual Growth Rate
4.1%
Value in USD Million
2026-2035
Read more about this report - Request a Free Sample
The Brazil Infusion Bags Market comprises a broad range of sterile medical containers used for the intravenous administration of fluids, electrolytes, parenteral nutrition, blood and blood components, dialysis solutions, and injectable medications. The market includes intravenous (IV) solution bags, total parenteral nutrition (TPN) bags, blood bags, dialysis solution bags, specialty infusion bags, and associated fluid delivery systems manufactured using PVC and non-PVC materials. Infusion bags play a vital role in fluid management, drug delivery, nutritional support, and transfusion therapy across hospitals, ambulatory surgical centers, specialty clinics, and home healthcare settings. The market was valued at USD 23.82 Million in 2025, driven by the rising prevalence of chronic diseases requiring intravenous therapy, increasing surgical procedures and hospital admissions, growing demand for home-based infusion care, expanding adoption of DEHP-free and non-PVC infusion bags, supportive healthcare investments across Brazil, and continuous advancements in sterile manufacturing technologies, material innovation, and infusion safety systems.
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Rising chronic disease burden, expanding intravenous therapies, increasing surgeries, and hospital infrastructure investments drive infusion bag demand. | In 2025, B. Braun expanded infusion technology investments and strengthened its IV solutions portfolio, supporting Brazil's growing healthcare demand. |
|
Market Restraints |
High manufacturing costs, stringent regulatory compliance, raw material price fluctuations, and economic instability limit market expansion. | Rising medical-grade polymer costs, inflation, and exchange-rate volatility increase production expenses, slowing adoption of advanced non-PVC infusion bags. |
|
Market Opportunities |
Growing adoption of sustainable non-PVC infusion products and expansion of home infusion services create long-term market opportunities. | In 2025, B. Braun promoted DEHP- and PVC-free IV containers, supporting sustainability, patient safety, and expanding outpatient infusion care. |
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Rising Chronic Disease Burden and Expanding Intravenous Care Accelerate Infusion Bag Demand
Brazil's growing burden of chronic diseases, ageing demographics, and increasing surgical procedures continue to strengthen demand for infusion bags used in hydration, chemotherapy, parenteral nutrition, dialysis, and biologic administration. As per Pérez-Granda et al., 2025, safe vascular access and intravenous therapy remain central to modern hospital care. Recent product innovation has also reinforced market momentum; in 2025, B. Braun expanded investments in infusion technologies and manufacturing while strengthening its IV solutions portfolio. Stable public healthcare expenditure across Brazil and improving capital investment in hospital infrastructure further support procurement despite persistent inflationary pressures.
High Manufacturing Costs and Regulatory Compliance Challenges Restrain Market Growth
The Brazil infusion bags market faces significant challenges due to the high costs associated with manufacturing non-PVC infusion bags and complying with stringent regulatory and quality standards. Transitioning from conventional PVC materials to safer DEHP-free alternatives requires substantial investment in advanced production technologies, product validation, and regulatory approvals. Additionally, fluctuations in the prices of medical-grade polymers, packaging materials, and other raw materials increase production costs and place pressure on manufacturers' profit margins. From a macroeconomic perspective, persistent inflation, elevated financing costs, and exchange-rate volatility continue to increase operating expenses, limiting investment capacity and slowing the widespread adoption of advanced infusion bag technologies across Brazil.
Sustainable Non-PVC Technologies and Home Infusion Expand Long-Term Growth Opportunities
The transition toward environmentally sustainable infusion products presents significant opportunities for manufacturers across Brazil. According to B. Braun, 2025, healthcare providers are increasingly adopting IV containers manufactured without DEHP or PVC to improve patient safety and drug compatibility while supporting sustainability objectives. Simultaneously, the gradual expansion of outpatient infusion services, selected home infusion programs, and biologic therapies is increasing demand for advanced infusion systems. From a macroeconomic perspective, continued public and private healthcare investment and increasing localization of medical device manufacturing are strengthening long-term market prospects despite elevated financing costs and exchange-rate volatility.
Rapid Transition Toward Non-PVC and DEHP-Free Infusion Bags Emerges as the Defining Market Trend
The most significant trend shaping the Brazil infusion bags market is the gradual transition from conventional PVC infusion bags to non-PVC, DEHP-free alternatives, driven by evolving national medical device regulations, increasing patient safety requirements, and growing interest in sustainable healthcare practices. According to B. Braun, 2025, healthcare providers are increasingly adopting infusion containers manufactured without PVC or DEHP to improve drug compatibility and patient safety. During 2025, manufacturers continued expanding non-PVC production capacity and introducing advanced multilayer polymer technologies to support regional demand. From a macroeconomic perspective, increasing healthcare investment, gradual localization of medical device manufacturing, and continued modernization of hospital infrastructure are strengthening long-term market prospects despite persistent raw material price volatility and relatively high financing costs.
Read more about this report - Request a Free Sample
Intravenous Fluid Therapy is Likely to Dominate Market Share by Application
Intravenous fluid therapy represents the largest application segment in the Brazil infusion bags market owing to its indispensable role in managing dehydration, electrolyte imbalance, perioperative care, sepsis, trauma, oncology, and critical care across hospitals and outpatient settings. As per National Institute for Health and Care Excellence (NICE), 2025, intravenous fluid therapy remains a fundamental component of adult inpatient care, supported by evidence-based clinical guidelines that continue to shape procurement practices across Europe and Brazil. During 2025, B. Braun and Baxter International continued strengthening their intravenous solutions portfolios and manufacturing capabilities to ensure supply resilience amid growing clinical demand. From a macroeconomic perspective, sustained public healthcare investment, ageing populations, and increasing hospital utilization continue to support long-term demand for IV fluid administration despite persistent inflationary pressures on healthcare procurement.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
B. Braun SE remains one of Brazil's leading infusion therapy companies, reporting continued revenue growth driven by its Hospital Care and Avitum divisions. Its infusion portfolio includes PVC-free IV solution bags, parenteral nutrition containers, elastomeric infusion systems, and automated infusion technologies. Operating in more than 60 countries with products available in over 190 markets, the company maintains a strong global healthcare footprint. During 2024–2025, B. Braun expanded investments in pharmaceutical manufacturing capacity and digital infusion solutions to strengthen supply resilience. The company operates under ISO 13485-certified quality systems, with products carrying CE Marking, MDR compliance, and other international regulatory certifications.
Becton, Dickinson and Company reported solid financial performance during 2024–2025, supported by its medical segment and Medication Management Solutions business. The company's infusion portfolio includes IV bags, prefillable systems, infusion sets, vascular access devices, and smart medication delivery technologies. BD serves healthcare providers in more than 190 countries through a broad manufacturing and distribution network. In 2025, the company continued expanding connected medication management platforms and infusion safety technologies while investing in manufacturing efficiency. BD maintains ISO 13485-certified facilities, CE Marked products, U.S. FDA compliance, and extensive global regulatory approvals.
Fresenius Kabi AG continued strengthening its financial position in 2024–2025 through growth in clinical nutrition, infusion therapy, and biopharmaceutical businesses. The company offers a comprehensive portfolio including IV solution bags, parenteral nutrition bags, drug admixture systems, infusion pumps, and oncology preparations. Operating across more than 100 countries, Fresenius Kabi serves hospitals, pharmacies, and outpatient providers worldwide. Recent investments focused on sterile pharmaceutical manufacturing expansion and enhanced Brazilian production capabilities to improve supply security. The company complies with ISO 13485, EU Medical Device Regulation (MDR), CE Marking requirements, and Good Manufacturing Practice (GMP) standards.
ICU Medical continued integrating its infusion therapy portfolio following previous acquisitions, supporting steady business performance throughout 2024–2025. Its offerings include IV solution containers, infusion pumps, IV administration sets, needle-free connectors, and oncology infusion systems. The company supplies healthcare providers in more than 100 countries, emphasizing medication safety and infusion workflow optimization. During 2024–2025, ICU Medical expanded manufacturing capacity and introduced enhancements to its Plum and LifeShield infusion platforms. Its manufacturing facilities comply with ISO 13485, FDA Quality System Regulation (QSR), CE Marking, and multiple international quality standards.
Other key players in the market include Nipro Corporation, Terumo Corporation, Baxter International Inc., KIEFEL GmbH, Gilead Sciences, Inc. and PolyCine GmbH.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
The Brazil infusion bags market is segmented by product type based on the intended clinical use of infusion containers across healthcare settings. Product innovation, increasing hospital admissions, expanding chronic disease management, and rising demand for sterile fluid administration continue to support adoption across diverse therapeutic applications.
Market Breakup by Material
The market is segmented by material according to the polymer composition used in manufacturing infusion bags. Material selection is influenced by drug compatibility, patient safety, environmental regulations, flexibility, sterilization performance, and the growing transition toward safer, DEHP-free, and non-PVC alternatives across Brazil healthcare systems.
Market Breakup by Capacity
The market is segmented by capacity based on the volume of fluid delivered for different therapeutic requirements. Capacity selection varies according to treatment protocols, patient population, infusion duration, and clinical applications ranging from small-dose medications to large-volume hydration and nutritional support.
Market Breakup by Application
The market is segmented by application according to the clinical purpose for which infusion bags are utilized. Increasing demand for intravenous therapies, critical care services, nutritional support, renal disease treatment, and blood transfusion procedures continues to expand the use of infusion bags across multiple therapeutic disciplines.
Market Breakup by End User
The market is segmented by end users based on the healthcare facilities utilizing infusion bags for patient treatment. Demand is supported by expanding hospital infrastructure, rising outpatient procedures, increasing home-based care, and the growing need for efficient intravenous therapy across diverse clinical environments.
Market Breakup by Distribution Channel
The market is segmented by distribution channel according to the primary pathways through which infusion bags are supplied to healthcare providers and patients. Distribution efficiency, procurement practices, digital pharmacy expansion, and healthcare accessibility influence purchasing patterns across the Brazilian market.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Material |
|
| Breakup by Capacity |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.